(LANC) Lancaster Colony - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5138471033

LANC: Frozen Bread, Salad Dressings, Dips, Croutons, Pasta Sauces

Lancaster Colony Corporation, trading under NASDAQ:LANC, is a notable player in the specialty food sector, focusing on manufacturing and marketing for both retail and foodservice channels. Their operations are divided into two segments: Retail and Foodservice, which together form a robust structure for their market approach.

The company boasts a diverse portfolio of products, including frozen garlic bread under the New York BRAND Bakery label and Parkerhouse rolls under Sister Schuberts. Their salad dressings are marketed through several brands: Marzetti, Cardinis, Simply Dressed, and Girards. Additionally, they offer vegetable and fruit dips under Marzetti, and croutons and toppings through New York BRAND Bakery, Chatham Village, and Marzetti. Their frozen pasta line also falls under the Marzetti brand, showcasing their comprehensive range in the frozen food category.

Beyond their own brands, Lancaster Colony leverages strategic partnerships, manufacturing products for well-known restaurants such as Olive Garden, Buffalo Wild Wings, and Chick-fil-A. This diversification not only enhances their revenue streams but also underscores their reliability as a supplier. Their distribution network includes direct sales personnel, food brokers, and distributors, ensuring wide market penetration across retailers and restaurants.

Financially, Lancaster Colony presents a market cap of $5.2 billion, with a trailing P/E of 32.99 and a forward P/E of 36.50, indicating investor confidence in their growth prospects. Their price-to-book ratio of 5.28 and price-to-sales of 2.77 highlight a premium valuation, reflecting their strong market position and brand equity in the packaged foods sector. Established in 1961 and headquartered in Westerville, Ohio, the companys longevity and consistent performance position it as a stable entity in a competitive industry.

Additional Sources for LANC Stock

LANC Stock Overview

Market Cap in USD 4,827m
Sector Consumer Defensive
Industry Packaged Foods
GiC Sub-Industry Packaged Foods & Meats
IPO / Inception 1990-03-26

LANC Stock Ratings

Growth Rating 26.5
Fundamental 74.3
Dividend Rating 59.1
Rel. Strength -15
Analysts 3.29/5
Fair Price Momentum 179.33 USD
Fair Price DCF 142.24 USD

LANC Dividends

Dividend Yield 12m 2.02%
Yield on Cost 5y 2.84%
Annual Growth 5y 5.07%
Payout Consistency 94.5%

LANC Growth Ratios

Growth Correlation 3m 15.1%
Growth Correlation 12m -22.7%
Growth Correlation 5y 57.2%
CAGR 5y 7.22%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 0.26
Alpha -6.25
Beta 0.317
Volatility 34.31%
Current Volume 102.3k
Average Volume 20d 136.4k
What is the price of LANC stocks?
As of April 16, 2025, the stock is trading at USD 184.76 with a total of 102,283 shares traded.
Over the past week, the price has changed by +6.28%, over one month by +0.85%, over three months by +10.59% and over the past year by -3.24%.
Is Lancaster Colony a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Lancaster Colony (NASDAQ:LANC) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 74.31 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LANC as of April 2025 is 179.33. This means that LANC is currently overvalued and has a potential downside of -2.94%.
Is LANC a buy, sell or hold?
Lancaster Colony has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold LANC.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for LANC stock price target?
According to ValueRays Forecast Model, LANC Lancaster Colony will be worth about 194.5 in April 2026. The stock is currently trading at 184.76. This means that the stock has a potential upside of +5.25%.
Issuer Forecast Upside
Wallstreet Target Price 205.2 11.1%
Analysts Target Price 197.6 6.9%
ValueRay Target Price 194.5 5.3%